NuVasive received regulatory approval for the minimally disruptive posterior fixation device in July.
The company opened a Tokyo office in April, and surgeon proctors have started to schedule training courses and surgeries with the Precept.
More Articles on Devices:
Stryker Buys MAKO Surgical for $1.65B
Spinal Elements Celebrates Hero Allograft Anniversary, Donates $250k to Children’s Charities
Study: Roughened Titanium Alloy Surface Better Enhances Fusion Than Smooth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
